A long campaign halved the percentage of U.S. smokers. Could a similar effort succeed against the nation’s obesity epidemic?
Therapies that focus on tumors’ key proteins have had miraculous but often short-lived effects. New strategies could extend their usefulness.
Using natural language processing and other advanced search tools, bioinformatics experts are mining patient files—and striking paydirt.
Synthetic biologists go far beyond genetic engineers, creating cellular computers, microbial drug factories and cancer-hunting bacteria.
What a hospital can do in the face of America's growing obesity problem, by Peter L. Slavin and David F. Torchiana.
Readers discuss hormone replacement therapy and the ethical use of robots.
These glasses offer a low-tech, low-cost, no-doctor solution for bad eyesight.
Saving time at the doctor’s office with same-day scheduling takes time to implement.
Paul A. Offit, an infectious disease specialist, discusses the costs of not vaccinating children for fear of autism.
Compelling ads offering loads of cash to perfect donors obscure much that is unknown about egg donation.
Medicina Curiosa, the first English-language medical journal, mixed the technical with the practical.
Some drugs lend extreme wakefulness and focus—but are the enhancements worth the risks?
In an effort to save money and increase quality of care for Medicare patients, the government is considering denying payment to hospitals for certain procedures.
Recent procedures bring new hope to face transplant candidates.
Sometimes being overbearing can save a life.